Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

citalopram

- PMLiVE

India revokes Pfizer’s patent on Sutent

Loses patent protection for kidney cancer drug after Cipla and Natco challenge

Teva pulls generic version of antidepressant Wellbutrin XL in US

FDA says copy is not equivalent to branded drug

- PMLiVE

Sanofi acquires Colombian pharma manufacturing firm Genfar

Expands its Latin American generics portfolio

- PMLiVE

German doctors criticise EU clinical trial reform plans

Could compromise patient safety says German Medical Association

Lundbeck files novel antidepressant vortioxetine in EU

Could counter loss of patent for big-selling Lexapro/Cipralex

- PMLiVE

Bayer fails to block Indian Nexavar compulsory licence

Loses ‘stay’ appeal against Natco Pharma in Chennai court

European Commission launches iCoach app to help smokers quit

The mobile anti-smoking campaign is part of the EC's on-going Ex-smokers are Unstoppable push

- PMLiVE

European Commission takes quit smoking campaign mobile

New iCoach Android and iPhone app is part of the EC's on-going Ex-smokers are Unstoppable push

Pfizer forms branded generics sales alliance in China

Forms joint venture with local company Hisun

- PMLiVE

Europe developing roadmap for mHealth use and acceptance

EU's MovingLife project is currently consulting on mHealth needs and requirements

- PMLiVE

European Commission wants tougher anti-smoking measures to halt spread of chronic diseases

Large number of young smokers will lead to further problems says EC's Martin Seychell at ERS congress

- PMLiVE

Interview: Michel Goldman, Innovative Medicines Initiative

The executive director of the Innovative Medicines Initiative explains the scope and successes of projects developed under this novel European partnership to Linda Banks

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links